CGMP-specific phosphodiesterase type 5

Content sourced from Wikipedia, licensed under CC BY-SA 3.0.

CGMP-specific phosphodiesterase type 5 (PDE5) is an enzyme that breaks down cyclic guanosine monophosphate (cGMP). It helps turn off signals that relax blood vessels, so it’s found in erectile tissue (penis and clitoris), the retina, and other tissues like the heart and blood vessels.

How it works
- When the body uses NO signaling, cGMP rises and helps muscles around blood vessels relax, increasing blood flow.
- PDE5 then lowers cGMP to end that signal. By blocking PDE5, medicines keep cGMP levels higher, helping blood vessels stay relaxed longer.

Why PDE5 inhibitors are used
- They treat erectile dysfunction by improving blood flow to the penis.
- They’re also used for pulmonary arterial hypertension and are studied for heart-related conditions.

Common PDE5 inhibitors
- Sildenafil (Viagra)
- Vardenafil (Levitra)
- Tadalafil (Cialis)
- Avanafil (Stendra)

Key points about the drugs
- They block the catalytic site of PDE5 and are selective for PDE5, which helps limit effects on other enzymes.
- They work best when there is sexual stimulation; they don’t cause an erection by themselves.
- They can have side effects such as headache, flushing, dizziness, nasal congestion, and vision changes.

Important cautions
- PDE5 inhibitors can interact with nitrates and some heart medications, potentially causing dangerous drops in blood pressure.
- They may cause light sensitivity or color vision changes at higher doses.

Other notes
- PDE5 is present in other tissues, including platelets and heart muscle, where its inhibition can influence blood flow and activity.
- The enzyme’s activity can be affected by the cell’s redox state and other cellular factors, which can influence how well inhibitors work.

In short, PDE5 helps regulate a key blood-flow signal, and PDE5 inhibitors boost that signal to help with erectile function and other conditions, with careful attention to side effects and drug interactions.